DGAP-Adhoc: Evonik Industries AG:
|
DGAP-Ad-hoc: Evonik Industries AG / Key word(s): Disposal
Evonik Industries AG:
04-March-2019 / 18:17 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Essen, 4 March 2019 - Evonik Industries AG and Advent International have agreed on the key terms of a sale of the methacrylates business for a purchase price in the amount of 3.0 billion EUR. The business comprises the Methacrylates, Acrylic Products and CyPlus business lines, and some of the methacrylate resins activities. The necessary approval by the Supervisory Board of Evonik Industries AG is still pending. The notarization of the corresponding purchase agreement is currently taking place.
Contact/Person making the notification:
Tim Lange
Head of Investor Relations
+49 201 177-3150
[email protected]
04-March-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
| Language: |
English |
| Company: |
Evonik Industries AG |
|
Rellinghauser Straße 1-11 |
|
45128 Essen |
|
Germany |
| Phone: |
+49 (0) 201 177-01 |
| Fax: |
+49 (0) 201 177-3475 |
| E-mail: |
[email protected] |
| Internet: |
www.evonik.com |
| ISIN: |
DE000EVNK013 |
| WKN: |
EVNK01 |
| Indices: |
MDAX |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Luxembourg Stock Exchange |
| |
| End of Announcement |
DGAP News Service |
783587 04-March-2019 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Umsatzerlöse1 |
14.419,00 |
15.024,00 |
13.108,00 |
12.199,00 |
14.955,00 |
18.488,00 |
15.267,00 |
| EBITDA1,2 |
2.357,00 |
2.150,00 |
2.153,00 |
1.837,00 |
2.246,00 |
2.510,00 |
1.598,00 |
| EBITDA-Marge3 |
16,35 |
14,31 |
16,43 |
15,06 |
15,02 |
13,58 |
|
| EBIT1,4 |
1.229,00 |
1.367,00 |
1.080,00 |
819,00 |
1.173,00 |
942,00 |
-243,00 |
| EBIT-Marge5 |
8,52 |
9,10 |
8,24 |
6,71 |
7,84 |
5,10 |
-1,59 |
| Jahresüberschuss1 |
734,00 |
954,00 |
2.127,00 |
479,00 |
767,00 |
555,00 |
-452,00 |
| Netto-Marge6 |
5,09 |
6,35 |
16,23 |
3,93 |
5,13 |
3,00 |
-2,96 |
| Cashflow1,7 |
1.551,00 |
1.704,00 |
1.321,00 |
1.727,00 |
1.815,00 |
1.650,00 |
1.594,00 |
| Ergebnis je Aktie8 |
1,54 |
2,00 |
4,52 |
1,00 |
1,60 |
1,16 |
-1,00 |
| Dividende8 |
1,15 |
1,15 |
1,15 |
1,15 |
1,17 |
1,17 |
1,15 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: KPMG
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Evonik Industries |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| EVNK01 |
19,615 |
Halten |
9.140,59 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 15,09 |
15,91 |
0,95 |
12,15 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 1,09 |
5,73 |
0,60 |
7,79 |
| Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23
in % |
Hauptversammlung |
| 1,17 |
1,17 |
5,96 |
28.05.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 12.05.2025 |
01.08.2024 |
06.11.2024 |
05.03.2025 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 2,80% |
5,95% |
6,03% |
10,13% |
|
|
Evonik Industries AG DE000EVNK013